Author

Joseph Gonzalez

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

OpenAlex ID: A5000501034

Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).

2012 · Ayca Gucalp, Sara M. Tolaney, et al. · Journal of Clinical Oncology · 31

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

2011 · Devika Gajria, Joseph Gonzalez, et al. · Breast Cancer Research and Treatment · 28

IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer.

2012 · Tiffany A. Traina, Clifford Hudis, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 59

H-index: 2

I10-index: 2